Immunophenotypic spectrum of plasma cell leukemia
β Scribed by Michael D. Linden; Andrew J. Fishleder; Raymond R. Tubbs; Hoon Park
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 370 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Four cases of plalsma cell leukemia (PCL) are reported that illustrate the variable immunotype of this disorder in contriast with the immunologic profile described for normal B-cell maturation and typical multiple myeloma (MM). Mature B-lymphocytes express B l antigen (Ag) and surface immunoglobulin (SIg) whereas maturation to the plasma cell stage is accompanied by loss of these immunologic markers and expression of T10 Ag, plasma cell Ag (PCA), and cytoplasmic immunoglobulin (CIg). Plasma cells from patients with MM have previously been found to express the immunophenotype of normal plasma cells. In contrast, none of the four cases reported here express an immunologic profile typical for specific B-cell differentiation stages. Only one of four cases was strongly positive for PCA but additionally expressed B1 Ag and SIg. Of the remaining three cases, all expressed T10 Ag and CIg; two cases also expressed SIg, weak PCA, and B1 Ag. All four cases were monoclonal for lambda light chains and negative for common ALL As: (CALLA). The variable expression of mature B-cell markers and plasma cell markers demonstrates the immunophenotypic spectrum of PCL; the prognostic significance of this heterogeneity needs to be more closely examined.
π SIMILAR VOLUMES
Fig. 1. Axial MRI showing many lesions in both hemispheres. High-Disseminated Aspergillosis After Mobilization With intensity signal on T2, with a moderate surrounding edema and Intensive Chemotherapy Prior to Autologous Stem-Cell effect of mass. ## Transplant in Chronic Myeloid Leukemia To the E
Use of a nonlinear prediction method, such as machine learning, is a valuable choice in predicting progression rate of disease when applied to the highly variable and correlated biological data such as those in patients with chronic lymphocytic leukemia (CLL). In this work, decision-tree approach to